(AME) Ametek - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0311001004

Instruments, Sensors, Motors, Batteries, Metals

AME EPS (Earnings per Share)

EPS (Earnings per Share) of AME over the last years for every Quarter: "2020-09-30": 1.01, "2020-12-31": 1.08, "2021-03-31": 1.07, "2021-06-30": 1.15, "2021-09-30": 1.26, "2021-12-31": 1.37, "2022-03-31": 1.33, "2022-06-30": 1.38, "2022-09-30": 1.45, "2022-12-31": 1.52, "2023-03-31": 1.49, "2023-06-30": 1.57, "2023-09-30": 1.64, "2023-12-31": 1.68, "2024-03-31": 1.64, "2024-06-30": 1.66, "2024-09-30": 1.47, "2024-12-31": 1.87, "2025-03-31": 1.52, "2025-06-30": 1.78,

AME Revenue

Revenue of AME over the last years for every Quarter: 2020-09-30: 1126.942, 2020-12-31: 1198.947, 2021-03-31: 1215.742, 2021-06-30: 1386.346, 2021-09-30: 1440.681, 2021-12-31: 1503.745, 2022-03-31: 1458.525, 2022-06-30: 1514.552, 2022-09-30: 1551.786, 2022-12-31: 1625.667, 2023-03-31: 1597.117, 2023-06-30: 1646.111, 2023-09-30: 1622.837, 2023-12-31: 1730.885, 2024-03-31: 1736.18, 2024-06-30: 1734.834, 2024-09-30: 1708.564, 2024-12-31: 1761.602, 2025-03-31: 1731.971, 2025-06-30: 1778.056,

Description: AME Ametek

AMETEK Inc (NYSE:AME) is a diversified manufacturer of electronic instruments and electromechanical devices, serving various industries globally, including aerospace, defense, oil and gas, pharmaceuticals, and food and beverage. The companys broad product portfolio is categorized into two main segments: Electronic Instruments Group (EIG) and Electromechanical Group (EMG).

The EIG segment provides advanced instruments for process control, aerospace, power, and industrial markets, while the EMG segment offers engineered components and devices, including medical components, automation solutions, and specialty metals. AMETEKs products are used in a wide range of applications, from laboratory equipment and ultra-precision manufacturing to aerospace and defense systems.

From a financial perspective, AMETEK has demonstrated a stable track record, with a market capitalization of approximately $41.8 billion. Key performance indicators (KPIs) such as Return on Equity (ROE) of 14.75% and a forward Price-to-Earnings (P/E) ratio of 25.77 suggest a relatively stable and profitable company. Additionally, AMETEKs dividend yield and payout ratio can be considered attractive for income investors.

To further evaluate AMETEKs investment potential, it is essential to analyze its revenue growth, profit margins, and cash flow generation. A review of the companys historical financial statements reveals a steady increase in revenue, driven by a combination of organic growth and strategic acquisitions. AMETEKs operating margins have also remained relatively stable, indicating effective cost management and pricing power.

From a valuation perspective, AMETEKs P/E ratio can be compared to that of its peers in the Electrical Components & Equipment sub-industry. Additionally, metrics such as Enterprise Value (EV) to Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) and Price-to-Book (P/B) ratio can provide further insights into the companys valuation relative to its industry peers.

AME Stock Overview

Market Cap in USD 43,865m
Sub-Industry Electrical Components & Equipment
IPO / Inception 1984-07-19

AME Stock Ratings

Growth Rating 56.5%
Fundamental 79.1%
Dividend Rating 59.0%
Return 12m vs S&P 500 -5.69%
Analyst Rating 4.11 of 5

AME Dividends

Dividend Yield 12m 0.66%
Yield on Cost 5y 1.24%
Annual Growth 5y 9.24%
Payout Consistency 94.7%
Payout Ratio 18.2%

AME Growth Ratios

Growth Correlation 3m 82.6%
Growth Correlation 12m 14.7%
Growth Correlation 5y 90%
CAGR 5y 17.30%
CAGR/Max DD 3y 0.75
CAGR/Mean DD 3y 3.42
Sharpe Ratio 12m -0.53
Alpha 0.02
Beta 0.915
Volatility 18.55%
Current Volume 1060.9k
Average Volume 20d 970.4k
Stop Loss 181.6 (-3%)
Signal -0.33

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income (1.44b TTM) > 0 and > 6% of Revenue (6% = 418.8m TTM)
FCFTA 0.11 (>2.0%) and ΔFCFTA 0.36pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 16.95% (prev 8.27%; Δ 8.69pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.12 (>3.0%) and CFO 1.81b > Net Income 1.44b (YES >=105%, WARN >=100%)
Net Debt (1.32b) to EBITDA (2.12b) ratio: 0.62 <= 3.0 (WARN <= 3.5)
Current Ratio 1.63 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (231.5m) change vs 12m ago -0.36% (target <= -2.0% for YES)
Gross Margin 36.12% (prev 35.65%; Δ 0.48pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 46.44% (prev 46.13%; Δ 0.31pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 21.97 (EBITDA TTM 2.12b / Interest Expense TTM 83.0m) >= 6 (WARN >= 3)

Altman Z'' 6.22

(A) 0.08 = (Total Current Assets 3.05b - Total Current Liabilities 1.87b) / Total Assets 15.27b
(B) 0.76 = Retained Earnings (Balance) 11.62b / Total Assets 15.27b
(C) 0.12 = EBIT TTM 1.82b / Avg Total Assets 15.03b
(D) 2.30 = Book Value of Equity 11.22b / Total Liabilities 4.88b
Total Rating: 6.22 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 79.06

1. Piotroski 6.50pt = 1.50
2. FCF Yield 3.73% = 1.86
3. FCF Margin 24.12% = 6.03
4. Debt/Equity 0.19 = 2.48
5. Debt/Ebitda 0.92 = 1.88
6. ROIC - WACC (= 3.60)% = 4.49
7. RoE 14.53% = 1.21
8. Rev. Trend 90.31% = 6.77
9. EPS Trend 56.52% = 2.83

What is the price of AME shares?

As of September 18, 2025, the stock is trading at USD 187.27 with a total of 1,060,917 shares traded.
Over the past week, the price has changed by +0.05%, over one month by +2.71%, over three months by +5.01% and over the past year by +11.97%.

Is Ametek a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Ametek (NYSE:AME) is currently (September 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 79.06 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AME is around 189.67 USD . This means that AME is currently overvalued and has a potential downside of 1.28%.

Is AME a buy, sell or hold?

Ametek has received a consensus analysts rating of 4.11. Therefore, it is recommended to buy AME.
  • Strong Buy: 10
  • Buy: 2
  • Hold: 5
  • Sell: 0
  • Strong Sell: 1

What are the forecasts/targets for the AME price?

Issuer Target Up/Down from current
Wallstreet Target Price 205.7 9.8%
Analysts Target Price 205.7 9.8%
ValueRay Target Price 212.5 13.5%

Last update: 2025-09-13 04:30

AME Fundamental Data Overview

Market Cap USD = 43.87b (43.87b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 619.7m USD (last quarter)
P/E Trailing = 30.5845
P/E Forward = 25.1256
P/S = 6.2842
P/B = 4.2691
P/EG = 2.7773
Beta = 1.1
Revenue TTM = 6.98b USD
EBIT TTM = 1.82b USD
EBITDA TTM = 2.12b USD
Long Term Debt = 1.53b USD (from longTermDebt, last quarter)
Short Term Debt = 407.7m USD (from shortTermDebt, last quarter)
Debt = 1.94b USD (Calculated: Short Term 407.7m + Long Term 1.53b)
Net Debt = 1.32b USD (from netDebt column, last quarter)
Enterprise Value = 45.19b USD (43.87b + Debt 1.94b - CCE 619.7m)
Interest Coverage Ratio = 21.97 (Ebit TTM 1.82b / Interest Expense TTM 83.0m)
FCF Yield = 3.73% (FCF TTM 1.68b / Enterprise Value 45.19b)
FCF Margin = 24.12% (FCF TTM 1.68b / Revenue TTM 6.98b)
Net Margin = 20.60% (Net Income TTM 1.44b / Revenue TTM 6.98b)
Gross Margin = 36.12% ((Revenue TTM 6.98b - Cost of Revenue TTM 4.46b) / Revenue TTM)
Tobins Q-Ratio = 4.03 (Enterprise Value 45.19b / Book Value Of Equity 11.22b)
Interest Expense / Debt = 0.87% (Interest Expense 16.9m / Debt 1.94b)
Taxrate = 17.18% (285.4m / 1.66b)
NOPAT = 1.51b (EBIT 1.82b * (1 - 17.18%))
Current Ratio = 1.63 (Total Current Assets 3.05b / Total Current Liabilities 1.87b)
Debt / Equity = 0.19 (Debt 1.94b / last Quarter total Stockholder Equity 10.39b)
Debt / EBITDA = 0.92 (Net Debt 1.32b / EBITDA 2.12b)
Debt / FCF = 1.15 (Debt 1.94b / FCF TTM 1.68b)
Total Stockholder Equity = 9.89b (last 4 quarters mean)
RoA = 9.42% (Net Income 1.44b, Total Assets 15.27b )
RoE = 14.53% (Net Income TTM 1.44b / Total Stockholder Equity 9.89b)
RoCE = 15.95% (Ebit 1.82b / (Equity 9.89b + L.T.Debt 1.53b))
RoIC = 12.62% (NOPAT 1.51b / Invested Capital 11.96b)
WACC = 9.02% (E(43.87b)/V(45.81b) * Re(9.39%)) + (D(1.94b)/V(45.81b) * Rd(0.87%) * (1-Tc(0.17)))
Shares Correlation 3-Years: 51.52 | Cagr: 0.03%
Discount Rate = 9.39% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 76.93% ; FCFE base≈1.64b ; Y1≈1.99b ; Y5≈3.27b
Fair Price DCF = 189.7 (DCF Value 43.81b / Shares Outstanding 231.0m; 5y FCF grow 22.85% → 3.0% )
EPS Correlation: 56.52 | EPS CAGR: 7.74% | SUE: 4.0 | # QB: 16
Revenue Correlation: 90.31 | Revenue CAGR: 5.07% | SUE: N/A | # QB: None

Additional Sources for AME Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle